These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15152192)

  • 1. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
    Wiegand HL; Doehle BP; Bogerd HP; Cullen BR
    EMBO J; 2004 Jun; 23(12):2451-8. PubMed ID: 15152192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
    Doehle BP; Schäfer A; Cullen BR
    Virology; 2005 Sep; 339(2):281-8. PubMed ID: 15993456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.
    Ribeiro AC; Maia e Silva A; Santa-Marta M; Pombo A; Moniz-Pereira J; Goncalves J; Barahona I
    J Virol; 2005 Jan; 79(2):823-33. PubMed ID: 15613310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
    Marin M; Rose KM; Kozak SL; Kabat D
    Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
    Nagao T; Yamashita T; Miyake A; Uchiyama T; Nomaguchi M; Adachi A
    J Med Invest; 2010 Feb; 57(1-2):89-94. PubMed ID: 20299747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.
    Simon JH; Miller DL; Fouchier RA; Malim MH
    Virology; 1998 Sep; 248(2):182-7. PubMed ID: 9721227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.
    Dang Y; Wang X; Esselman WJ; Zheng YH
    J Virol; 2006 Nov; 80(21):10522-33. PubMed ID: 16920826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
    Hultquist JF; Lengyel JA; Refsland EW; LaRue RS; Lackey L; Brown WL; Harris RS
    J Virol; 2011 Nov; 85(21):11220-34. PubMed ID: 21835787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity.
    Vetter ML; Johnson ME; Antons AK; Unutmaz D; D'Aquila RT
    PLoS Pathog; 2009 Feb; 5(2):e1000292. PubMed ID: 19197360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.
    Madani N; Kabat D
    J Virol; 1998 Dec; 72(12):10251-5. PubMed ID: 9811770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
    Zhou T; Han Y; Dang Y; Wang X; Zheng YH
    Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
    Ochsenbauer C; Wilk T; Bosch V
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
    Yu Q; Chen D; König R; Mariani R; Unutmaz D; Landau NR
    J Biol Chem; 2004 Dec; 279(51):53379-86. PubMed ID: 15466872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
    Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.
    Bertine M; Charpentier C; Visseaux B; Storto A; Collin G; Larrouy L; Damond F; Matheron S; Brun-Vézinet F; Descamps D;
    AIDS; 2015 Apr; 29(7):779-84. PubMed ID: 25985400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
    Madani N; Kabat D
    J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of vif genes derived from various primate immunodeficiency viruses.
    Yamamoto Y; Saito Y; Iida S; Asano J; Sone S; Adachi A
    Virus Genes; 1997; 14(3):195-200. PubMed ID: 9311564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.